Astrazeneca Pharma India Cash Flow Annual

Trade
BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | Sector: Major Drugs
6,455.40 +118.50 (1.87%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 219.54134.1083.04127.09
Depreciation/ Depletion 14.9416.2616.9520.13
Non- Cash Items -22.01-21.06-7.29-5.93
Changesin Working Capital -184.60-71.018.10-36.51
Cashfrom Operating Activities 27.8658.29100.80104.78
Capital Expenditures -10.76-8.52-9.62-7.71
Other Investing Cash Flow Items Total 32.5126.6314.36180.74
Cashfrom Investing Activities 21.7418.114.74173.03
Financing Cash Flow Items -0.52-0.63-0.95-1.09
Total Cash Dividends Paid -40.00-20.00-5.00-5.00
Issuance( Retirement)of Debt Net -3.86-3.85-3.51-2.88
Cashfrom Financing Activities -44.37-24.48-9.46-8.97
Net Changein Cash 5.2351.9296.08268.84
Cash Interest Paid 0.520.630.951.09
Cash Taxes Paid 56.4340.8224.7932.56
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts